What is the recommended dose of Keflex (cephalexin) for a child weighing 33 pounds with bullous impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Bullous Impetigo in a 33-pound Child

For a child weighing 33 pounds (15 kg) with bullous impetigo, the recommended dose of cephalexin is 25-50 mg/kg/day divided into 3-4 doses, which equals 375-750 mg per day total, or approximately 125-250 mg per dose given 3-4 times daily. 1

Dosing Calculation

To determine the appropriate cephalexin dose:

  • Child's weight: 33 pounds = 15 kg
  • Recommended dosage range: 25-50 mg/kg/day 1
  • Total daily dose: 375-750 mg/day

Dosing options:

  1. Four times daily regimen (preferred for impetigo):

    • 94-188 mg per dose (rounded to 100-200 mg) given every 6 hours
  2. Three times daily regimen (alternative):

    • 125-250 mg per dose given every 8 hours

Administration Considerations

  • Formulation: Cephalexin suspension is available in 125 mg/5 mL and 250 mg/5 mL concentrations 2
  • Duration: Treatment should continue for 7 days 1
  • Administration: Can be given with or without food
  • Storage: After reconstitution, the suspension should be refrigerated and is stable for 14 days 2

Evidence for Cephalexin in Bullous Impetigo

Cephalexin is highly effective for bullous impetigo, which is predominantly caused by Staphylococcus aureus:

  • The Infectious Diseases Society of America (IDSA) guidelines specifically recommend cephalexin as a first-line treatment for impetigo 1
  • Studies have demonstrated cephalexin's superior efficacy compared to penicillin for impetigo, with treatment failure rates of 0% for cephalexin versus 24% for penicillin V 3
  • Cephalexin has excellent activity against both S. aureus and Streptococcus pyogenes, the primary pathogens in impetigo 4

Practical Dosing Tips

  • For a 15 kg child using the 125 mg/5 mL suspension:

    • 1-2 teaspoons (5-10 mL) four times daily 2
    • OR 1.5-2 teaspoons (7.5-10 mL) three times daily
  • For a 15 kg child using the 250 mg/5 mL suspension:

    • 0.5-1 teaspoon (2.5-5 mL) four times daily 2
    • OR 0.75-1 teaspoon (3.75-5 mL) three times daily

Important Clinical Considerations

  • Monitoring: Watch for clinical improvement within 48-72 hours
  • Common side effects: Diarrhea (most common), nausea, rash
  • Allergies: Confirm absence of cephalosporin allergy before prescribing
  • Alternative options if cephalexin cannot be used:
    • Clindamycin: 20 mg/kg/day in 3 divided doses 1
    • Mupirocin ointment: For limited lesions, apply twice daily 1

Pitfalls to Avoid

  • Underdosing: Using adult dosing (250 mg QID) rather than weight-based dosing can lead to treatment failure
  • Inadequate duration: Stopping therapy prematurely can lead to recurrence
  • Overlooking MRSA: If no improvement occurs within 48-72 hours, consider MRSA coverage
  • Compliance issues: Four-times-daily dosing may be challenging; ensure caregivers understand the importance of adherence to the prescribed regimen

While three-times-daily dosing may improve compliance 5, the IDSA guidelines specifically recommend 3-4 divided doses for impetigo in children, with four-times-daily dosing being the traditional approach for optimal coverage 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Therapy for Dental and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.